Thromb Haemost 1986; 55(01): 031-033
DOI: 10.1055/s-0038-1661440
Original Article
Schattauer GmbH Stuttgart

High Plasma Levels of Protein C Activity and Antigen in the Nephrotic Syndrome

Pier Mannuccio Mannucci
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
,
Carla Valsecchi
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
,
Bianca Bottasso
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
,
Armando D'Angelo
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
,
Stefano Casati
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
,
Claudio Ponticelli
The A. Bianchi Bonomi Hemophilia and Thrombosis Center, and the Division of Nephrology and Dialysis, University and Maggiore Hospital, Milano,Italy
› Author Affiliations
Further Information

Publication History

Received 08 August 1985

Accepted 09 October 1985

Publication Date:
19 July 2018 (online)

Summary

Low plasma levels of antithrombin III due to excessive urinary loss are thought to be the cause of thrombotic complications in patients with the nephrotic syndrome. To see whether protein C (PC), another antithrombotic protein, is also reduced in plasma by the same mechanism, plasma and urinary protein C were determined in 24 patients with nephrotic syndrome and no thrombotic complication, and compared to plasma and urinary antithrombin III. Twenty patients (83%) had high plasma levels of protein C activity (mean ± SD 157 ± 41 U/dl) and antigen (158 ± 41). Even though measurable amounts of PC antigen were found in the urines of all but two patients the urinary loss of protein C relative to its plasma concentration was about 40 times lower than that of antithrombin III. High protein C might help to counteract hypercoagulability in nephrotic syndrome.

 
  • References

  • 1 Llach F. Nephrotic syndrome: hypercoagulability, renal vein thrombosis and other thromboembolic complications. In: Nephrotic Syndrome Brenner BM, Stein JH. (Eds) Churchill Livingstone; New York: 1982: 121-144
  • 2 Vaziri ND. Nephrotic syndrome and coagulation and fibrinolytic abnormalities. Am J Nephrol 1983; 3: 1-5
  • 3 Kaufmann RH, Veltkamp JJ, van Tilburg NH, van Es LA. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1978; 65: 607-613
  • 4 Thaler E, Balzar E, Kopsa H, Pinngera WF. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis 1978; 7: 257-272
  • 5 Esmon CT. Protein C: biochemistry, physiology and clinical implications. Blood 1984; 63: 15-17
  • 6 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
  • 7 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
  • 8 Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 80: 261-264
  • 9 Mannucci PM, Viganó S. Deficiency of protein C, an inhibitor of blood coagulation. Lancet 1982; 2: 463-466
  • 10 Sala N, Owen WG, Collen D. A functional assay for protein C in human plasma. Blood 1984; 63: 671-675
  • 11 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
  • 12 Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu MJ. A new method for the estimation of protein C by ELISA. Thromb Res 1984; 36: 579-589
  • 13 Vigano S, Mannucci PM, D’Angeló A, Gelfi C, Gensini GF, Rostagno C, Neri Serneri GG. Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes. Thromb Haemostas 1984; 52: 263-266
  • 14 Girot RF, Jaubert F, Leon M, Bellon B, Aiach M, Josso F, Lepelletier O, Beguin S, Monnet JP. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome. Thromb Haemostas 1983; 49: 13-17
  • 15 Deen WM, Meyers BD, Brenner BM. The glomerular barrier to macromacules, theoretical and experimental considerations. In: Nephrotic Syndrome Brenner BM, Stein JH. (Eds) Churchill Livingstone; New York: 1982: 1-29
  • 16 Rosenberg RD, Damus DS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
  • 17 Di Scipio RG, Davie EW. Characterization of protein S, gamma-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904
  • 18 Pabinger-Fasching I, Lechner K, Niessner H, Schmidt P, Balzar E, Mannhalter CH. High levels of plasma protein C in nephrotic syndrome. Thromb Haemostas 1985; 53: 5-7